Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888966315> ?p ?o ?g. }
Showing items 1 to 100 of
100
with 100 items per page.
- W2888966315 endingPage "138" @default.
- W2888966315 startingPage "130" @default.
- W2888966315 abstract "Inotropes are an integral component of the early stabilization of the patient presenting with cardiogenic shock. Despite years of clinical experience with the 2 most commonly used inotropes, dobutamine and milrinone, there remains limited data comparing outcomes between the two. We conducted a retrospective review to compare the effectiveness and safety of milrinone or dobutamine for the initial management of cardiogenic shock. Adult patients with cardiogenic shock regardless of etiology who received initial inotrope therapy with either milrinone (n = 50) or dobutamine (n = 50) and did not receive mechanical circulatory support were included. The primary end point was the time to resolution of cardiogenic shock. Changes in hemodynamic parameters from baseline and adverse events were also assessed. Resolution of shock was achieved in similar numbers in both the groups (milrinone 76% vs dobutamine 70%, P = .50). The median time to resolution of shock was 24 hours in both groups ( P = .75). There were no differences in hemodynamic changes during inotrope therapy, although dobutamine trended toward a greater increase in cardiac index. Arrhythmias were more common in patients treated with dobutamine than milrinone, respectively (62.9% vs 32.8%, P < .01), whereas hypotension occurred to a similar extent in both groups (milrinone 49.2% vs dobutamine 40.3%, P = .32). The use of concomitant vasoactive medications, dosage required, and duration of therapy did not differ between groups. There was no difference in the overall rate of discontinuation due to adverse event; however, milrinone was more commonly discontinued due to hypotension (13.1% vs 0%, P < .01) and dobutamine was more commonly discontinued due to arrhythmia (0% vs 11.3%, P < .01). Milrinone and dobutamine demonstrated similar effectiveness and safety profiles but with differences in adverse events. The choice of milrinone or dobutamine as initial inotrope therapy for cardiogenic shock may depend more on tolerability of adverse events." @default.
- W2888966315 created "2018-09-07" @default.
- W2888966315 creator A5001381139 @default.
- W2888966315 creator A5006472394 @default.
- W2888966315 creator A5012794059 @default.
- W2888966315 creator A5024070585 @default.
- W2888966315 creator A5025532006 @default.
- W2888966315 date "2018-09-02" @default.
- W2888966315 modified "2023-10-01" @default.
- W2888966315 title "Comparative Effectiveness and Safety Between Milrinone or Dobutamine as Initial Inotrope Therapy in Cardiogenic Shock" @default.
- W2888966315 cites W1968657635 @default.
- W2888966315 cites W1971300736 @default.
- W2888966315 cites W1974873560 @default.
- W2888966315 cites W1995529106 @default.
- W2888966315 cites W2024477873 @default.
- W2888966315 cites W2051827206 @default.
- W2888966315 cites W2052247886 @default.
- W2888966315 cites W2063412307 @default.
- W2888966315 cites W2095944485 @default.
- W2888966315 cites W2103275785 @default.
- W2888966315 cites W2106703370 @default.
- W2888966315 cites W2109784377 @default.
- W2888966315 cites W2129429230 @default.
- W2888966315 cites W2130232926 @default.
- W2888966315 cites W2135619337 @default.
- W2888966315 cites W2147195792 @default.
- W2888966315 cites W2149463609 @default.
- W2888966315 cites W2166950143 @default.
- W2888966315 cites W2301761598 @default.
- W2888966315 cites W2472746779 @default.
- W2888966315 cites W2569673837 @default.
- W2888966315 cites W2755584350 @default.
- W2888966315 cites W4205395603 @default.
- W2888966315 cites W4293372203 @default.
- W2888966315 doi "https://doi.org/10.1177/1074248418797357" @default.
- W2888966315 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30175599" @default.
- W2888966315 hasPublicationYear "2018" @default.
- W2888966315 type Work @default.
- W2888966315 sameAs 2888966315 @default.
- W2888966315 citedByCount "28" @default.
- W2888966315 countsByYear W28889663152020 @default.
- W2888966315 countsByYear W28889663152021 @default.
- W2888966315 countsByYear W28889663152022 @default.
- W2888966315 countsByYear W28889663152023 @default.
- W2888966315 crossrefType "journal-article" @default.
- W2888966315 hasAuthorship W2888966315A5001381139 @default.
- W2888966315 hasAuthorship W2888966315A5006472394 @default.
- W2888966315 hasAuthorship W2888966315A5012794059 @default.
- W2888966315 hasAuthorship W2888966315A5024070585 @default.
- W2888966315 hasAuthorship W2888966315A5025532006 @default.
- W2888966315 hasConcept C126322002 @default.
- W2888966315 hasConcept C139940330 @default.
- W2888966315 hasConcept C155710745 @default.
- W2888966315 hasConcept C164705383 @default.
- W2888966315 hasConcept C178853913 @default.
- W2888966315 hasConcept C197934379 @default.
- W2888966315 hasConcept C2776645727 @default.
- W2888966315 hasConcept C2776850375 @default.
- W2888966315 hasConcept C2781185063 @default.
- W2888966315 hasConcept C2781300812 @default.
- W2888966315 hasConcept C31861589 @default.
- W2888966315 hasConcept C42219234 @default.
- W2888966315 hasConcept C500558357 @default.
- W2888966315 hasConcept C71924100 @default.
- W2888966315 hasConceptScore W2888966315C126322002 @default.
- W2888966315 hasConceptScore W2888966315C139940330 @default.
- W2888966315 hasConceptScore W2888966315C155710745 @default.
- W2888966315 hasConceptScore W2888966315C164705383 @default.
- W2888966315 hasConceptScore W2888966315C178853913 @default.
- W2888966315 hasConceptScore W2888966315C197934379 @default.
- W2888966315 hasConceptScore W2888966315C2776645727 @default.
- W2888966315 hasConceptScore W2888966315C2776850375 @default.
- W2888966315 hasConceptScore W2888966315C2781185063 @default.
- W2888966315 hasConceptScore W2888966315C2781300812 @default.
- W2888966315 hasConceptScore W2888966315C31861589 @default.
- W2888966315 hasConceptScore W2888966315C42219234 @default.
- W2888966315 hasConceptScore W2888966315C500558357 @default.
- W2888966315 hasConceptScore W2888966315C71924100 @default.
- W2888966315 hasIssue "2" @default.
- W2888966315 hasLocation W28889663151 @default.
- W2888966315 hasLocation W28889663152 @default.
- W2888966315 hasOpenAccess W2888966315 @default.
- W2888966315 hasPrimaryLocation W28889663151 @default.
- W2888966315 hasRelatedWork W2063412307 @default.
- W2888966315 hasRelatedWork W2419750755 @default.
- W2888966315 hasRelatedWork W2789560201 @default.
- W2888966315 hasRelatedWork W2888966315 @default.
- W2888966315 hasRelatedWork W3166211984 @default.
- W2888966315 hasRelatedWork W3211094715 @default.
- W2888966315 hasRelatedWork W4285122815 @default.
- W2888966315 hasRelatedWork W4286314364 @default.
- W2888966315 hasRelatedWork W4296612791 @default.
- W2888966315 hasRelatedWork W586430160 @default.
- W2888966315 hasVolume "24" @default.
- W2888966315 isParatext "false" @default.
- W2888966315 isRetracted "false" @default.
- W2888966315 magId "2888966315" @default.
- W2888966315 workType "article" @default.